Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced
Zixue Xuan1,2, Jian Song3, Quanjun Yang4
1Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
Frontiers in Immunology
|November 29, 2023
Abstract
No abstract available in PubMed .


